继续骗_老虎社区_美港股上老虎

2022-07-28

继续骗

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":682671052,"tweetId":"682671052","gmtCreate":1658992299779,"gmtModify":1658992299779,"author":{"id":3546003306043139,"idStr":"3546003306043139","authorId":3546003306043139,"authorIdStr":"3546003306043139","name":"傻傻过","avatar":"https://static.tigerbbs.com/6f948d3adb99e1d19b67d17cfdb18ee0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>继续骗</p></body></html>","htmlText":"<html><head></head><body><p>继续骗</p></body></html>","text":"继续骗","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/682671052","repostId":2254953643,"repostType":2,"repost":{"id":"2254953643","kind":"news","pubTimestamp":1658962623,"share":"https://www.laohu8.com/m/news/2254953643?lang=&edition=full","pubTime":"2022-07-28 06:57","market":"us","language":"zh","title":"Teladoc Health Q2净亏损31亿，全年业绩预期不乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=2254953643","media":"智通财经","summary":"智通财经APP获悉，周三美股盘后，远程医疗服务公司Teladoc Health公布二季度财报。具体来说，Teladoc预计2022财年营收在24亿至25亿美元之间，调整后的EBITDA在2.4亿至2.65亿美元之间，每股净亏损为62美元至61美元。截至发稿，Teladoc盘后跌超23%，报33.25美元。值得一提的是，Teladoc高管在第一季度计入63亿美元的商誉减值费用后，在第二季度披露了30亿美元的商誉减值费用，使其今年前六个月的总亏损达到近100亿美元。截至二季度末，Teladoc的现金和现金等价物为8.812亿美元。","content":"<html><head></head><body><p>周三美股盘后，远程医疗服务公司<a href=\"https://laohu8.com/S/TDOC\">Teladoc Health</a>公布二季度财报。财报显示，该公司Q2营收5.924亿美元，同比增长18%;净亏损31亿美元，其中包括30.3亿美元的非现金商誉减值费用、5100万美元的股票补偿费用和4910万美元的收购无形资产摊销，合每股亏损19.22美元，而上年同期亏损1.338亿美元，合每股亏损0.86美元。</p><p>此外，Teladoc还公布调整后的息税折旧及摊销前利润(EBITDA)为4,670万美元，低于上年同期的6,680万美元，而分析师此前预计为4,530万美元。最后，该公司管理层预计，根据目前市场趋势，将维持2022财年收入和调整后的利息、税项、折旧及摊销前利润(EBITDA)区间，但预计业绩将处于较低端。</p><p>具体来说，Teladoc预计2022财年营收在24亿至25亿美元之间，调整后的EBITDA在2.4亿至2.65亿美元之间，每股净亏损为62美元至61美元。截至发稿，Teladoc盘后跌超23%，报33.25美元。</p><p>值得一提的是，Teladoc高管在第一季度计入63亿美元的商誉减值费用后，在第二季度披露了30亿美元的商誉减值费用，使其今年前六个月的总亏损达到近100亿美元。截至二季度末，Teladoc的现金和现金等价物为8.812亿美元。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc Health Q2净亏损31亿，全年业绩预期不乐观</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc Health Q2净亏损31亿，全年业绩预期不乐观\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-28 06:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/762438.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>周三美股盘后，远程医疗服务公司Teladoc Health公布二季度财报。财报显示，该公司Q2营收5.924亿美元，同比增长18%;净亏损31亿美元，其中包括30.3亿美元的非现金商誉减值费用、5100万美元的股票补偿费用和4910万美元的收购无形资产摊销，合每股亏损19.22美元，而上年同期亏损1.338亿美元，合每股亏损0.86美元。此外，Teladoc还公布调整后的息税折旧及摊销前利润(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/762438.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","relate_stocks":{"TDOC":"Teladoc Health Inc.","BK4548":"巴美列捷福持仓","BK4167":"医疗保健技术","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4504":"桥水持仓"},"source_url":"http://www.zhitongcaijing.com/content/detail/762438.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2254953643","content_text":"周三美股盘后，远程医疗服务公司Teladoc Health公布二季度财报。财报显示，该公司Q2营收5.924亿美元，同比增长18%;净亏损31亿美元，其中包括30.3亿美元的非现金商誉减值费用、5100万美元的股票补偿费用和4910万美元的收购无形资产摊销，合每股亏损19.22美元，而上年同期亏损1.338亿美元，合每股亏损0.86美元。此外，Teladoc还公布调整后的息税折旧及摊销前利润(EBITDA)为4,670万美元，低于上年同期的6,680万美元，而分析师此前预计为4,530万美元。最后，该公司管理层预计，根据目前市场趋势，将维持2022财年收入和调整后的利息、税项、折旧及摊销前利润(EBITDA)区间，但预计业绩将处于较低端。具体来说，Teladoc预计2022财年营收在24亿至25亿美元之间，调整后的EBITDA在2.4亿至2.65亿美元之间，每股净亏损为62美元至61美元。截至发稿，Teladoc盘后跌超23%，报33.25美元。值得一提的是，Teladoc高管在第一季度计入63亿美元的商誉减值费用后，在第二季度披露了30亿美元的商誉减值费用，使其今年前六个月的总亏损达到近100亿美元。截至二季度末，Teladoc的现金和现金等价物为8.812亿美元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":995,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/682671052"}